|
Primary Care Edition
Annual Author Index 2005
[ Subject | Author ]
[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
X | Y | Z ]
A
Amory JK, see Clark B (Jun:28-31)
back to top
B
Beard M
The need for early recognition and treatment of osteoporosis to prevent fractures. Jan:9-15
Beattie MS
Breast cancer risk reduction. Oct:13-16
Bender BG
Screening patients for nonadherence. Feb:34-37
Beusterien KM, see Simon JA (Aug:12-17)
Brandes JL
Strategies for menstrual migraine prevention and treatment. Dec(suppl):11-14
Brannon K, , see Frohman EM (May:41-46; Jun:45-50)
Brunton SA
Serotonergic agents in the treatment of irritable bowel syndrome: a safety review. Dec:12-16
The value of C-reactive protein in the clinical assessment of cardiovascular disease risk. Jun:11-16
Why wonÕt patients do what theyÕre told? May:9-10
back to top
C
Cady RK
The pathophysiology and diagnosis of menstrual migraine. Dec(suppl):8-10
Cady RK
The pathophysiology and diagnosis of menstrual migraine. Dec(suppl):8-10
Chlebowski RT, see Geller ML (Jun:21-26)
Clark B
Contraception in the perimenopausal woman. Aug:26-30
Educating tomorrowÕs physicians in reproductive health. Dec:34-36
Family planning for obese women: challenges and opportunities. Oct:34-37
Research in male contraception. Jun:28-31
Creinin MD
Another contraceptive choice: the single-rod implant. Feb:38-43
back to top
D
Davis A
A practical guide to thyroid disease in women. Dec:38-46
Duke JM, see Ventolini G (Feb:20-26)
Dunn M, see Ventolini G (Feb:20-26)
back to top
F
Frohman EM
Multiple sclerosis and the female patient, part 1: characterizing the disease process. May:41-46
Multiple sclerosis and the female patient, part 2: clinical manifestations and symptomatic treatment strategies. Jun:45-50
Frohman TC, see Frohman EM (May:41-46; Jun:45-50)
back to top
G
Gaudet T, see Hottinger (May:36-40)
Gelber SE
Update on vulvovaginal candidiasis. Apr:25-31
Geller ML
The role of aromatase inhibitors in breast cancer therapy. Jun:21-26
Giesser B, see Frohman EM (May:41-46; Jun:45-50)
Grimes D, see Clark B (Oct:34-37)
back to top
H
Hall JA, see Ventolini G (Feb:20-26)
Hara JH
Update on hypertension in women. Mar:37-42
Hebborn A, see Simon JA (Aug:12-17)
Heller GV, see Mieres JH (Dec:21-26)
Hendel RC, see Mieres JH (Dec:21-26)
Henderson VW
Memory complaints. Aug:24-25
Herbelin S, see Sulak PJ (May:29-35)
Hess LW, see Weiss PM (Jan:31-34)
Hoskins IA
Health issues relating to women in the armed forces during and after deployment: a review. May:18-22
Hossain SA, see Stolzer J (Jan:24-30)
Hottinger G
A dietary prescription for menopause and beyond. May:36-40
Hudson T
Hyperlipidemia: nutritional, botanical, and life-style influences. Jan:41-45
Hurd WW, see Ventolini G (Feb:20-26)
Hurlburt J, see Clark B (Dec:34-36)
back to top
J
Jones KP, see Clark B (Aug:26-30)
back to top
K
Kagan R
Fractures and falls: minimizing the risks. Jun:32-33
Kalro RN
An overview of female infertility. Jan:16-23,40
Kaunitz AM
Depot medroxyprogesterone acetate injectable contraception in adolescents: reassuring data regarding skeletal health. Aug:10-11
Karram MM
Pharmacologic treatment of overactive bladder: review and comparison. Mar:16-21
Kightlinger RS
Vaginal atrophy: clinical evaluation and management. Apr:41-42
Kingsberg S
Loss of sexual desire and menopause: prevalence, causes, and impact on quality of life. Mar:22-28
back to top
L
Lakos G
Systemic sclerosis: symptoms, diagnosis, and treatment. Feb:8-12
Langer-Gould A, see Frohman EM (May:41-46; Jun:45-50)
Lazarus CJ, see Clark B (Dec:34-36)
Leidy NK, see Simon JA (Aug:12-17)
Levalds C, see Frohman EM (May:41-46; Jun:45-50)
Lias JL
Physical activity and young adult women: maximizing benefit, minimizing risk. Jun:40-44
Lovett-Racke A, see Frohman EM (May:41-46; Jun:45-50)
Lowery K, see Weiss PM (Jan:31-34)
Lundquist LM
Novel treatments for polycystic ovary syndrome. Dec:29-33
back to top
M
MacGregor EA
Combination oral contraceptives and migraine: is there an increased risk for ischemic stroke? Apr:37-40
McCullough LB, see Chervenak FA (Aug:11-12)
Mieres JH
Noninvasive testing for coronary artery disease in women. Dec:21-26
Monticciolo DL
Breast imaging update: mammography, ultrasonography, and magnetic resonance imaging. Mar:10-15
back to top
N
Nader S, see Davis A (Dec:38-46)
Ninia JG
Endoluminal varicose vein therapy. Aug:31-32,37-39
Nolan TE
Liability reform should be an access issue, not a money issue. Apr:8-9
My most memorable moment. Oct:26
Novielli KD
Polypharmacy: plague or panacea? Jun:9-10
Nyirjesy P, see Gelber SE (Apr:25-31)
back to top
P
Podymow T
Update: hypertension in pregnancy. Feb:28-33
Pomerantz RG
Depression during pregnancy. Aug:18-23
back to top
R
Resnick E, see Wider J (Mar:43-48)
back to top
S
Schlenk EA, see Lias JL (Jun:40-44)
Schwerha JJ, see Starz TW (Aug:40-44)
Shaw LJ, see Mieres JH (Dec:21-26)
Sherif K
Polycystic ovary syndrome in primary care. May:24-28
Shulman LP
Epidemiology and characteristics of menstrual migraine: too much pain for too long. Dec:4-7
Introduction [menstrual migraine CME supplement]. Dec(suppl):3,7
My most memorable moment: despite our best efforts. Dec:27-28
Simon JA
Bisphosphonate dosing preferences in women with postmenopausal osteoporosis: a study. Aug:12-17
Simon V
Sexually transmitted infections in women: an overview. Jun:34-39
Starz TW
Nonsteroidal anti-inflammatory drugs: understanding the risks and benefits. Feb:13-19,33
The obesity epidemic: itÕs spreading. Feb:7
Osteoarthritis of the knee in women. Aug:40-44
See also Lias JL (Jun:40-44)
Stolzer J
Physician breast-feeding education: a regional assessment. Jan:24-30
Sulak PJ
Teenagers and sex: delaying sexual debut. May:29-35
back to top
T
Taylor RB
Evidence-based clinical guidelines are grandÑor are they? Dec:10-11
Learning from the service experts. Jan:7-8
Temte JL
Lyme disease in women: recognition, treatment, and prevention. Oct:38-44
Thacker HL
Menopausal hormone therapy: the symptomatic patient. Apr:16-22
Treadaway K, see Frohman EM (May:41-46; Jun:45-50)
Trope L
Family practice and the female patient. Mar:8
Tsai C-J
Risk factors for cholelithiasis in women. Jan:35-40
back to top
U
Unger J
Diagnosis and management of diabetic peripheral neuropathic pain. Oct:27-33
Fine-tuning physiologic insulin replacement therapy via office downloading of home blood glucose monitoring data. Mar:29-36
Utian WH
Bioidentical hormones: separating science from marketing. Oct:23-24
Postmenopausal hormone therapy: clarifying the role. Feb:44-45
back to top
V
van Dam RM
Coffee/caffeine consumption and womenÕs health. Apr:32-36
Varga J, see Lakos G (Feb:8-12)
Velasko S
Women, cardiovascular disease, and screening for type 2 diabetes. Apr:10-14
Ventolini G
Breast cancer screening for primary care physicians. Feb:20-26
Vogt MT, see Starz TW (Feb:13-19,33; Aug:40-44)
back to top
W
Walsh C
Update on cervical cancer. May:11-16,28
Waubant E, see Frohman EM (May:41-46; Jun:45-50)
Weiss PM
YouÕve got e-mail: physician-patient electronic communication. Jan:31-34
Wider J
Gender differences in posttraumatic stress disorder. Mar:43-48
See also Simon V (Jun:34-39)
Wild RA
Fertility changes during perimenopause. Dec:19-20
Winslow H, see Frohman EM (May:41-46; Jun:45-50)
Wisner KL, see Pomerantz RG (Aug:18-23)
Waubant E, see Frohman EM (May:41-46; Jun:45-50)
back to top
|
